Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Filings indexed 319 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Standalone & Consolidated ....
Regulatory Filings Classification · 85% confidence The document is an intimation of a Board Meeting under SEBI Listing Obligations (Regulation 29/30), notifying the stock exchange of a future board meeting to consider and approve financial results. It does not contain the actual financial results or auditor’s report, nor is it announcing a management change or publishing a report itself. Therefore, it is a general regulatory announcement and best fits the Regulatory Filings category (RNS).
2026-05-12 English
Appointment
Regulatory Filings
2026-04-11 English
Price movement
Regulatory Filings Classification · 100% confidence The document text is extremely short (85 characters) and contains no substantive content, only placeholders and an omitted picture. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal or empty content defaults to Regulatory Filings (RNS) as a fallback category.
2026-04-09 English
Trading Window
Regulatory Filings
2026-03-20 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-03-09 English
Resignation
Regulatory Filings
2026-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.